What’s New in Ontosight® Terminal 1.1 A Complete Guide toRead More
What’s New in Ontosight® Terminal 1.1
CASE STUDIES & WHITEPAPERS
WHITEPAPER
Autoimmune Innovation Index Second Edition
This report captures the evolving clinical landscape across autoimmune diseases, featuring key global pharma and biotech players working on novel therapeutic modalities to advance these diseases. Download PDF
WHITEPAPER
AUTOIMMUNE INDEX REPORT
Autoimmune Index report provides you with a perspective on the new commercial and clinical opportunities by assessing their clinical innovation aspect. Innoplexus’ AI based CTP engine was leveraged to predict the success probability of clinical assets. Download PDFWHITEPAPER
INNOPLEXUS’ CTP MODEL
Innoplexus’ CTP model forecasts the outcome of clinical studies and may serve as an early indicator for future stock movements. Download PDF
WHITEPAPER
GENE THERAPY
Gene therapy promises to hold the cure to a number of diseases which, until now, have been considered incurable. By replacing a faulty gene in a patient’s DNA or repairing a defective gene by gene editing, gene therapy can provide a one-time treatment option for diseases such as genetic blindness, muscular dystrophy, blood cancer. Read our recent whitepaper: Advancements in gene therapy – usage of AAV vectors here. Download PDFWHITEPAPER
EMERGENCE OF CHIMERIC ANTIGEN
Emergence of chimeric antigen receptor-t (CAR-T) cell therapies for cancer treatment Download PDF
CASE STUDY
PIPELINE PRIORITIZATION
Continuously-Updating pipeline prioritization platform
Key Takeaways:
- Biological Validation: Identifying and validating potential uses of target, pathway, disease and drug candidates.
- Clinical Trial Valuation: Estimating costs of clinical trials and likelihood of success.
- Commercial Evaluation: Monitoring competitors and determining commercial opportunity.
CASE STUDY
DATA AS A SERVICE
DAAS APIS to power enterprise artificial intelligence
Key Takeaways:
- Finding most recent literature from congresses, presentation, clinical trials etc. based on indication and top pathways & targets being studied.
- Identifying competing drugs and drugs’ details such as pathway, targets, sponsors etc.
- Finding top investigators, ideal sites, and optimal design parameters for clinical trials.
CASE STUDY
CLINICAL OPTIMIZATION & SITE ENROLLMENT
Identify trial sites & patient enrolment across various parameters
Key Takeaways:
- Evaluating trial sites based on a client-specific filter system.
- Identifying & segmenting KOLs across asset classes and involvement.
- Integrating third-party and enterprise data to gain unique insights.
CASE STUDY
SENTIMENT WATCH
Understanding patient sentiment in real-time
Key Takeaways:
- Comparing share of voice against competitors across multiple dimensions.
- Analyzing trend momentum of social sentiments, positive, and negative sentiments share.
- Gaining insights from social and clinical media around Therapeutic Area (TA), indications, and different drugs.
CASE STUDY
THERAPEUTIC AREA LANDSCAPE DASHBOARDING
Commercial & business intelligence dashboard
Key Takeaways:
- Centralizing clinical, medical, commercial, and regulatory information in a single dashboard.
- Monitoring competitor activities and benchmarking performance against theirs.
- Providing real-time regulatory insights and changes in clinical guidelines.
CASE STUDY
LEAD IDENTIFICATION
Accelerate & Validate lead identification for drug design
Key Takeaways:
- Identifying efficacious drug candidates with real-world evidence and chemical descriptors.
- Reducing the cost and time of the demanding lead identification process.
- Providing access to the largest chemical library for QSAR.
CASE STUDY
KOL DISCOVERY & MANAGEMENT
Identifying key opinion leaders for engagement
Key Takeaways:
- Identifying top & emerging KOLs by archetypes- thought leader, scientific, speaker, commercial.
- Discovering the right set of Investigators for your planned clinical trial.
- Getting comprehensive view into highly influential KOLs, their activities, and associations.
CASE STUDY
TARGET IDENTIFICATION
Accelerating target identification for drug design
Key Takeaways:
- Identifying optimal targets based on efficacy, safety, clinical and commercial requirements.
- Narrowing target selection by using in-silico validation.
- Validating targets based on data of scientific literature.
CASE STUDY
ENDOTYPE RESPONSE & PERSONALIZED MEDICINE
Continuously-updating pipeline prioritization platform
Key Takeaways:
- Biological Validation: Identifying and validating potential uses of target, pathway, disease and drug candidates.
- Clinical Trial Valuation: Estimating costs of clinical trials and likelihood of success.
- Commercial Evaluation: Monitoring competitors and determining commercial opportunity.
